PT  - JOURNAL ARTICLE
AU  - Leipold, Alexander M.
AU  - Werner, Rudolf A.
AU  - Düll, Johannes
AU  - Jung, Pius
AU  - John, Mara
AU  - Stanojkovska, Emilia
AU  - Zhou, Xiang
AU  - Hornburger, Hannah
AU  - Ruckdeschel, Anna
AU  - Dietrich, Oliver
AU  - Imdahl, Fabian
AU  - Krammer, Tobias
AU  - Knop, Stefan
AU  - Rosenwald, Andreas
AU  - Buck, Andreas
AU  - Sander, Leif Erik
AU  - Einsele, Hermann
AU  - Kortüm, K. Martin
AU  - Saliba, Antoine-Emmanuel
AU  - Rasche, Leo
TI  - Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma
AID  - 10.1101/2022.12.08.22283148
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.08.22283148
4099  - http://medrxiv.org/content/early/2022/12/08/2022.12.08.22283148.short
4100  - http://medrxiv.org/content/early/2022/12/08/2022.12.08.22283148.full
AB  - Pseudo-progression and flare-up phenomena constitute a novel diagnostic challenge in the follow-up of patients treated with immune-oncology drugs. We present a case study on pulmonary flare-up after Idecabtagen Vicleucel (Ide-cel), a BCMA targeting CAR T-cell therapy, and used single-cell RNA-seq (scRNA-seq) to identify a Th17.1 driven autoimmune mechanism as the biological underpinning of this phenomenon. By integrating datasets of various lung pathological conditions, we revealed transcriptomic similarities between post CAR T pulmonary lesions and sarcoidosis. Furthermore, we explored a noninvasive PET based diagnostic approach and showed that tracers binding to CXCR4 complement FDG PET imaging in this setting, allowing discrimination between immune-mediated changes and true relapse after CAR T-cell treatment. In conclusion, our study highlights a Th17.1 driven autoimmune phenomenon after CAR T, which may be misinterpreted as disease relapse, and that imaging with multiple PET tracers and scRNA-seq could help in this diagnostic dilemma.Competing Interest StatementLeo Rasche. has participated in scientific advisory boards for Janssen, Celgene/Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, and Sanofi, has received research support from Skyline Dx, and has received honoraria from Janssen, Celgene/Bristol-Myers Squibb, Amgen, Pfizer, and Sanofi. Hermann Einsele has participated in scientific advisory boards for Janssen, Celgene/Bristol-Myers Squibb, Amgen, Novartis, and Takeda; has received research support from Janssen, Celgene/Bristol-Myers Squibb, Amgen, and Novartis; and has received honoraria from Janssen, Celgene/Bristol-Myers Squibb, Amgen, Novartis, and Takeda. The remaining authors declare no conflict of interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of University of Wuerzburg (reference # 8/21) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE145926 https://ega-archive.org/studies/EGAS00001004928 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184735 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169147 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE143317 https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-9139